Epigenetic Rewiring of BCR Signaling as a Novel Mechanism of Ibrutinib Resistance in ABC-DLBCL

Pasqualucci, L. (2021). Epigenetic Rewiring of BCR Signaling as a Novel Mechanism of Ibrutinib Resistance in ABC-DLBCL. Blood Cancer Discovery, 2(6), 555–558. https://doi.org/10.1158/2643-3230.bcd-21-0131
Authors:
Laura Pasqualucci
Affiliated Authors:
Laura Pasqualucci
Publication Type:
Article
Unique ID:
10.1158/2643-3230.BCD-21-0131
PMID:
Publication Date:
Data Source:
Scopus

Record Created: